Obesity management: Time-restricted eating and injection risks

New research and medical experts are highlighting different approaches and risks associated with obesity management. A study published in the journal Obesity, supported by the National Institutes of Health and the American Heart Association, suggests that time-restricted eating (TRE)—consuming food within a regular 8- to 10-hour daily window—can lead to moderate weight loss in adults with obesity or type 2 diabetes, even without intentional calorie restriction.

Parallel to dietary timing, pharmacological treatments such as weight-loss injections are gaining popularity. While medical professionals note these drugs can reduce the risk of heart attack and stroke by up to 20 percent, they warn of side effects like ‘Ozempic face.’ This phenomenon involves a loss of facial volume and increased wrinkles due to rapid subcutaneous fat loss. Experts emphasize that these medications should be used alongside physical activity to ensure weight loss includes fat rather than muscle mass.